You have 9 free searches left this month | for more free features.

Condition

Acute Coronary Syndrome (1)

Atrial Fibrillation (1)

CADASIL (1)

Hypercholesterolemia (1)

Overall Status

Completed (2)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 4 (1)

Sponsor

Pfizer (1)

S. Andrea Hospital (1)

Sanofi (1)

Collaborator

Regeneron Pharmaceuticals (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

antiplatelets

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Study to Explore OAC Treatment in Korea

Completed

Has Results

Atrial Fibrillation

Apixaban
+4 more

Seoul, Korea, Republic of

Korea University Hospital

Feb 10, 2020

Hypercholesterolemia, Acute Coronary Syndrome Trial in Japan (Alirocumab SAR236553, Atorvastatin, Rosuvastatin)

Completed

Has Results

Hypercholesterolemia
Acute Coronary Syndrome

Alirocumab SAR236553
+7 more

Bunkyō-Ku, Japan
+38 more

Jul 26, 2019

CADASIL Trial in Rome (Dabigatran, Antiplatelets)

Unknown status

CADASIL

Dabigatran
Antiplatelets

Rome, Italy
+1 more

Feb 10, 2014